{"id":"W4306411260","doi":"10.1002/clc.23926","title":"Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD","year":2022,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Esperion Therapeutics; Insmed; Moderna; Agios Pharmaceuticals; ARCA Biopharma; Cook Medical; Regeneron Pharmaceuticals; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Prothena; Alexion Pharmaceuticals; Yale University; Alnylam Pharmaceuticals; Brigham and Women's Hospital; Kowa Company; Sanofi; Audentes Therapeutics; Amgen; Pfizer","keywords":"Medicine; Rivaroxaban; Hazard ratio; Amputation; Surgery; Myocardial infarction; Aspirin; Revascularization; Stroke (engine); Population; Internal medicine; Critical limb ischemia; Confidence interval; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001293683,0.0002217907,0.002148387,0.000236791,0.00005360315,0.000004724108,0.0001682221,0.0001411225,0.001316775],"category_scores_gemma":[0.0008858769,0.0001955367,0.001165809,0.0004616409,0.0004238422,0.00003335286,0.00056121,0.0003699044,0.000009609803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008394271,"about_ca_system_score_gemma":0.00007842227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009589651,"about_ca_topic_score_gemma":0.00003006151,"domain_scores_codex":[0.9964626,0.0009723008,0.001280087,0.0006442097,0.0003293713,0.0003114617],"domain_scores_gemma":[0.9954425,0.002998549,0.0003257023,0.0008783807,0.0001032354,0.0002516177],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05679996,0.0003652825,0.9308913,0.00003130068,0.006373129,0.0004183224,0.00007088869,0.0001281849,0.00005007501,0.000006808774,0.001756436,0.003108284],"study_design_scores_gemma":[0.006204118,0.0006918957,0.9743998,0.00001079373,0.005830107,0.000004260316,0.00009061999,0.0001958818,7.176194e-7,0.000007622724,0.01239549,0.000168703],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961743,0.0004920723,0.00007726973,0.001099616,0.0007875201,0.000330465,0.0006028945,0.00003277965,0.0004030243],"genre_scores_gemma":[0.9980212,0.0000823931,0.0001118209,0.001116221,0.0001494076,0.00006332126,0.0002901174,0.00002021653,0.0001452994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05059583,"threshold_uncertainty_score":0.9995962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05346899791071398,"score_gpt":0.3472235257317107,"score_spread":0.2937545278209967,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}